Chronic Interactions Between Carotid Baroreceptors and Chemoreceptors in Obesity Hypertension

Hypertension

Volumn 68, Issue 1, 2016, Pages 227-235

  Lohmeier, Thomas E ^a   Iliescu, Radu ^b   Tudorancea, Ionut ^b   Cazan, Radu ^c   Cates, Adam W ^d   Georgakopoulos, Dimitrios ^d   Irwin, Eric D ^e  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c Department of Automation and Measurement   (United States)

^d CVRX INC   (United States)

^e NORTH MEMORIAL MEDICAL CENTER   (United States)

Author keywords

baroreflex; blood pressure; carotid bodies; hypertension; obesity; sympathetic nervous system

Indexed keywords

OXYGEN;

ARTICLE; BREATHING RATE; CAROTID BODY CHEMORECEPTOR; CAROTID SINUS PRESSORECEPTOR REFLEX; CONTROLLED STUDY; EXPERIMENTAL DOG; HEART RATE; HYPERCAPNIA; HYPERTENSION; HYPOXEMIA; LIPID DIET; MEAN ARTERIAL PRESSURE; NONHUMAN; OBESITY; PARTIAL PRESSURE; PRIORITY JOURNAL; WEIGHT GAIN; ADVERSE EFFECTS; ANIMAL; CAROTID BODY; CHEMORECEPTOR CELL; COMPLICATION; DISEASE MODEL; DOG; ELECTROSTIMULATION; HYPOXIA; METABOLISM; PATHOPHYSIOLOGY; PRESSORECEPTOR; PROCEDURES; RANDOMIZATION; TACHYPNEA; TREATMENT OUTCOME;

ANIMALS; CAROTID BODY; CHEMORECEPTOR CELLS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DOGS; ELECTRIC STIMULATION; HYPERTENSION; HYPOXIA; OBESITY; PRESSORECEPTORS; RANDOM ALLOCATION; TACHYPNEA; TREATMENT OUTCOME;

EID: 84966283575     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.07232     Document Type: Article

References (51)

1. Paton JF, Ratcliffe L, Hering D, Wolf J, Sobotka PA, Narkiewicz K. Revelations about carotid body function through its pathological role in resistant hypertension. Curr Hypertens Rep. 2013;15:273-280. doi: 10.1007/s11906-013-0366-z.
2. Trzebski A, Tafil M, Zoltowski M, Przybylski J. Increased sensitivity of the arterial chemoreceptor drive in young men with mild hypertension. Cardiovasc Res. 1982;16:163-172.
3. Somers VK, Mark AL, Abboud FM. Potentiation of sympathetic nerve responses to hypoxia in borderline hypertensive subjects. Hypertension. 1988;11(6 pt 2):608-612.
4. Przybylski J, Trzebski A, Czyzewski T, Jodkowski J. Responses to hypoxia, hypercapnia and almitrine in spontaneous hypertensive rats. Bull Europ Physiopath Respir. 1982;18:145-154.
5. Izdebska E, Cybulska I, Sawicki M, Izdebski J, Trzebski A. Postexercise decrease in arterial blood pressure, total peripheral resistance and in circulatory responses to brief hyperoxia in subjects with mild essential hypertension. J Hum Hypertens. 1998;12:855-860.
6. Siński M, Lewandowski J, Przybylski J, Bidiuk J, Abramczyk P, Ciarka A, Gaciong Z. Tonic activity of carotid body chemoreceptors contributes to the increased sympathetic drive in essential hypertension. Hypertens Res. 2012;35:487-491. doi: 10.1038/hr.2011.209.
7. McBryde FD, Abdala AP, Hendy EB, Pijacka W, Marvar P, Moraes DJ, Sobotka PA, Paton JF. The carotid body as a putative therapeutic target for the treatment of neurogenic hypertension. Nat Commun. 2013;4:2395. doi: 10.1038/ncomms3395.
8. Paton JF, Sobotka PA, Fudim M, Engelman ZJ, Engleman ZJ, Hart EC, McBryde FD, Abdala AP, Marina N, Gourine AV, Lobo M, Patel N, Burchell A, Ratcliffe L, Nightingale A. The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases. Hypertension. 2013;61:5-13. doi: 10.1161/HYPERTENSIONAHA.111.00064.
9. Abdala AP, McBryde FD, Marina N, Hendy EB, Engelman ZJ, Fudim M, Sobotka PA, Gourine AV, Paton JF. Hypertension is critically dependent on the carotid body input in the spontaneously hypertensive rat. J Physiol. 2012;590:4269-4277. doi: 10.1113/jphysiol.2012.237800.
10. Heistad DD, Abboud FM, Mark AL, Schmid PG. Interaction of baroreceptor and chemoreceptor reflexes. Modulation of the chemoreceptor reflex by changes in baroreceptor activity. J Clin Invest. 1974;53:1226-1236. doi: 10.1172/JCI107669.
11. Heistad D, Abboud FM, Mark AL, Schmid PG. Effect of baroreceptor activity on ventilatory response to chemoreceptor stimulation. J Appl Physiol. 1975;39:411-416.
12. Somers VK, Mark AL, Abboud FM. Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans. J Clin Invest. 1991;87:1953-1957. doi: 10.1172/JCI115221.
13. Lohmeier TE, Iliescu R. Chronic lowering of blood pressure by carotid baroreflex activation: mechanisms and potential for hypertension therapy. Hypertension. 2011;57:880-886. doi: 10.1161/HYPERTENSIONAHA.108.119859.
14. Lohmeier TE, Iliescu R. The sympathetic nervous system in obesity hypertension. Curr Hypertens Rep. 2013;15:409-416. doi: 10.1007/s11906-013-0356-1.
15. Gassler JP, Bisognano JD. Baroreflex activation therapy in hypertension. J Hum Hypertens. 2014;28:469-474. doi: 10.1038/jhh.2013.139.
16. Iliescu R, Tudorancea I, Lohmeier TE. Baroreflex activation: from mechanisms to therapy for cardiovascular disease. Curr Hypertens Rep. 2014;16:453. doi: 10.1007/s11906-014-0453-9.
17. Chobanyan-Jürgens K, Jordan J. Electrical carotid sinus stimulation: chances and challenges in the management of treatment resistant arterial hypertension. Curr Hypertens Rep. 2015;17:587. doi: 10.1007/s11906-015-0587-4.
18. Shibao C, Gamboa A, Diedrich A, Ertl AC, Chen KY, Byrne DW, Farley G, Paranjape SY, Davis SN, Biaggioni I. Autonomic contribution to blood pressure and metabolism in obesity. Hypertension. 2007;49:27-33. doi: 10.1161/01.HYP.0000251679.87348.05.
19. Grassi G, Mark A, Esler M. The sympathetic nervous system alterations in human hypertension. Circ Res. 2015;116:976-990. doi: 10.1161/CIRCRESAHA.116.303604.
20. Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116:991-1006. doi: 10.1161/CIRCRESAHA.116.305697.
21. Sood A. Altered resting and exercise respiratory physiology in obesity. Clin Chest Med. 2009;30:445-454, vii. doi: 10.1016/j. ccm.2009.05.003.
22. Salome CM, King GG, Berend N. Physiology of obesity and effects on lung function. J Appl Physiol (1985). 2010;108:206-211. doi: 10.1152/japplphysiol.00694.2009.
23. Littleton SW. Impact of obesity on respiratory function. Respirology. 2012;17:43-49. doi: 10.1111/j.1440-1843.2011.02096.x.
24. Verbraecken J, McNicholas WT. Respiratory mechanics and ventilatory control in overlap syndrome and obesity hypoventilation. Respir Res. 2013;14:132. doi: 10.1186/1465-9921-14-132.
25. Lohmeier TE, Dwyer TM, Irwin ED, Rossing MA, Kieval RS. Prolonged activation of the baroreflex abolishes obesity-induced hypertension. Hypertension. 2007;49:1307-1314. doi: 10.1161/HYPERTENSIONAHA.107.087874.
26. Lohmeier TE, Iliescu R, Liu B, Henegar JR, Maric-Bilkan C, Irwin ED. Systemic and renal-specific sympathoinhibition in obesity hypertension. Hypertension. 2012;59:331-338. doi: 10.1161/HYPERTENSIONAHA.111.185074.
27. Lohmeier TE, Iliescu R, Dwyer TM, Irwin ED, Cates AW, Rossing MA. Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex. Am J Physiol Heart Circ Physiol. 2010;299:H402-H409. doi: 10.1152/ajpheart.00372.2010.
28. Hayano J, Yasuma F. Hypothesis: respiratory sinus arrhythmia is an intrinsic resting function of cardiopulmonary system. Cardiovasc Res. 2003;58:1-9.
29. Lohmeier TE, Irwin ED, Rossing MA, Serdar DJ, Kieval RS. Prolonged activation of the baroreflex produces sustained hypotension. Hypertension. 2004;43:306-311. doi: 10.1161/01.HYP.0000111837.73693.9b.
30. Holmes C, Eisenhofer G, Goldstein DS. Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl. 1994;653:131-138.
31. Lohmeier TE, Liu B, Hildebrandt DA, Cates AW, Georgakopoulos D, Irwin ED. Global- and renal-specific sympathoinhibition in aldosterone hypertension. Hypertension. 2015;65:1223-1230. doi: 10.1161/HYPERTENSIONAHA.115.05155.
32. Rodman JR, Curran AK, Henderson KS, Dempsey JA, Smith CA. Carotid body denervation in dogs: eupnea and the ventilatory response to hyperoxic hypercapnia. J Appl Physiol (1985). 2001;91:328-335.
33. Haskins S, Pascoe PJ, Ilkiw JE, Fudge J, Hopper K, Aldrich J. Reference cardiopulmonary values in normal dogs. Comp Med. 2005;55:156-161.
34. Blain GM, Smith CA, Henderson KS, Dempsey JA. Peripheral chemoreceptors determine the respiratory sensitivity of central chemoreceptors to CO(2). J Physiol. 2010;588 (pt 13):2455-2471. doi: 10.1113/jphysiol.2010.187211.
35. Mifflin SW. Inhibition of chemoreceptor inputs to nucleus of tractus solitarius neurons during baroreceptor stimulation. Am J Physiol. 1993;265(1 pt 2):R14-R20.
36. Katayama PL, Castania JA, Dias DP, Patel KP, Fazan R Jr, Salgado HC. Role of chemoreceptor activation in hemodynamic responses to electrical stimulation of the carotid sinus in conscious rats. Hypertension. 2015;66:598-603. doi: 10.1161/HYPERTENSIONAHA.115.05316.
37. Neil E, Redwood CR, Schweitzer A. Pressor responses to electrical stimulation of the carotid sinus nerve in cats. J Physiol. 1949;109:259-271.
38. Levy MN, Zieske H. Effect of carotid sinus nerve stimulation pattern on cardiorespiratory responses. Am J Physiol. 1976;230:951-958.
39. Alnima T, Goedhart EJ, Seelen R, van der Grinten CP, de Leeuw PW, Kroon AA. Baroreflex activation therapy lowers arterial pressure without apparent stimulation of the carotid bodies. Hypertension. 2015;65:1217-1222. doi: 10.1161/HYPERTENSIONAHA.114.04354.
40. Lohmeier TE, Hildebrandt DA, Dwyer TM, Barrett AM, Irwin ED, Rossing MA, Kieval RS. Renal denervation does not abolish sustained baroreflex-mediated reductions in arterial pressure. Hypertension. 2007;49:373-379. doi: 10.1161/01.HYP.0000253507.56499.bb.
41. Thrasher TN, Shifflett C. Effect of carotid or aortic baroreceptor denervation on arterial pressure during hemorrhage in conscious dogs. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1642-R1649.
42. Van Vliet BN, Chafe LL, Montani JP. Contribution of baroreceptors and chemoreceptors to ventricular hypertrophy produced by sino-aortic denervation in rats. J Physiol. 1999;516(pt 3):885-895.
43. Daly MD, Scott MJ. The cardiovascular responses to stimulation of the carotid body chemoreceptors in the dog. J Physiol. 1963;165:179-197.
44. Van Vliet BN, Hall JE, Mizelle HL, Montani JP, Smith MJ Jr. Reduced parasympathetic control of heart rate in obese dogs. Am J Physiol. 1995;269(2 pt 2):H629-H637.
45. Iliescu R, Tudorancea I, Irwin ED, Lohmeier TE. Chronic baroreflex activation restores spontaneous baroreflex control and variability of heart rate in obesity-induced hypertension. Am J Physiol Heart Circ Physiol. 2013;305:H1080-H1088. doi: 10.1152/ajpheart.00464.2013.
46. Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, Wiesner GH, Brunner-La Rocca HP, Esler MD. Neural mechanisms in human obesity-related hypertension. J Hypertens. 1999;17: 1125-1133.
47. Blain GM, Smith CA, Henderson KS, Dempsey JA. Contribution of the carotid body chemoreceptors to eupneic ventilation in the intact, unanesthetized dog. J Appl Physiol (1985). 2009;106:1564-1573. doi: 10.1152/japplphysiol.91590.2008.
48. Lazarus R, Sparrow D, Weiss ST. Effects of obesity and fat distribution on ventilatory function: the normative aging study. Chest. 1997;111:891-898.
49. Zavorsky GS, Murias JM, Kim do J, Gow J, Sylvestre JL, Christou NV. Waist-to-hip ratio is associated with pulmonary gas exchange in the morbidly obese. Chest. 2007;131:362-367. doi: 10.1378/chest.06-1513.
50. Sutherland TJ, Goulding A, Grant AM, Cowan JO, Williamson A, Williams SM, Skinner MA, Taylor DR. The effect of adiposity measured by dual-energy X-ray absorptiometry on lung function. Eur Respir J. 2008;32:85-91. doi: 10.1183/09031936.00112407.
51. Alvarez GE, Ballard TP, Beske SD, Davy KP. Subcutaneous obesity is not associated with sympathetic neural activation. Am J Physiol Heart Circ Physiol. 2004;287:H414-H418. doi: 10.1152/ajpheart.01046.2003.